These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 1864255

  • 1. [Treatment of resistant depression with the citalopram-lithium combination. Methodology of a double-blind multicenter study and preliminary results].
    Souche A, Montaldi S, Uehlinger C, Kasas A, Reymond MJ, Reymond P, Baumann P, Dufour H.
    Encephale; 1991; 17(3):213-9. PubMed ID: 1864255
    [Abstract] [Full Text] [Related]

  • 2. A double-blind, placebo-controlled study of citalopram with and without lithium in the treatment of therapy-resistant depressive patients: a clinical, pharmacokinetic, and pharmacogenetic investigation.
    Baumann P, Nil R, Souche A, Montaldi S, Baettig D, Lambert S, Uehlinger C, Kasas A, Amey M, Jonzier-Perey M.
    J Clin Psychopharmacol; 1996 Aug; 16(4):307-14. PubMed ID: 8835706
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and tolerability of mirtazapine versus citalopram: a double-blind, randomized study in patients with major depressive disorder. Nordic Antidepressant Study Group.
    Leinonen E, Skarstein J, Behnke K, Agren H, Helsdingen JT.
    Int Clin Psychopharmacol; 1999 Nov; 14(6):329-37. PubMed ID: 10565799
    [Abstract] [Full Text] [Related]

  • 4. [Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatoninergic agonist and selective 5HT2C receptors antagonist, in the treatment of major depressive disorders].
    Lôo H, Daléry J, Macher JP, Payen A.
    Encephale; 2002 Nov; 28(4):356-62. PubMed ID: 12232545
    [Abstract] [Full Text] [Related]

  • 5. [Pilot study comparing in blind the therapeutic effect of two doses of agomelatine, melatonin- agonist and selective 5HT2c receptors antagonist, in the treatment of major depressive disorders].
    Lôo H, Daléry J, Macher JP, Payen A.
    Encephale; 2003 Nov; 29(2):165-71. PubMed ID: 14567168
    [Abstract] [Full Text] [Related]

  • 6. Effect of clomipramine and lithium on fenfluramine-induced hormone release in major depression.
    Shapira B, Yagmur MJ, Gropp C, Newman M, Lerer B.
    Biol Psychiatry; 1992 May 15; 31(10):975-83. PubMed ID: 1511080
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A randomized controlled trial of duloxetine versus placebo in the treatment of nonmajor chronic depression.
    Hellerstein DJ, Stewart JW, McGrath PJ, Deliyannides DA, Batchelder ST, Black SR, Withers A, O'Shea D, Chen Y.
    J Clin Psychiatry; 2012 Jul 15; 73(7):984-91. PubMed ID: 22901348
    [Abstract] [Full Text] [Related]

  • 11. Multicenter double-blind randomized parallel-group clinical trial of efficacy of the combination clomipramine (150 mg/day) plus lithium carbonate (750 mg/day) versus clomipramine (150 mg/day) plus placebo in the treatment of unipolar major depression.
    Januel D, Poirier MF, D'alche-Biree F, Dib M, Olié JP.
    J Affect Disord; 2003 Sep 15; 76(1-3):191-200. PubMed ID: 12943949
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV.
    Clin Ther; 2007 Nov 15; 29(11):2319-32. PubMed ID: 18158074
    [Abstract] [Full Text] [Related]

  • 14. Using non-steroidal anti-inflammatory drugs in the treatment of depression.
    Davis A, Gilhooley M, Agius M.
    Psychiatr Danub; 2010 Nov 15; 22 Suppl 1():S49-52. PubMed ID: 21057403
    [Abstract] [Full Text] [Related]

  • 15. Open-label treatment with desvenlafaxine in postmenopausal women with major depressive disorder not responding to acute treatment with desvenlafaxine or escitalopram.
    Soares CN, Thase ME, Clayton A, Guico-Pabia CJ, Focht K, Jiang Q, Kornstein SG, Ninan PT, Kane CP.
    CNS Drugs; 2011 Mar 15; 25(3):227-38. PubMed ID: 21323394
    [Abstract] [Full Text] [Related]

  • 16. The vasopressin V(1b) receptor antagonist SSR149415 in the treatment of major depressive and generalized anxiety disorders: results from 4 randomized, double-blind, placebo-controlled studies.
    Griebel G, Beeské S, Stahl SM.
    J Clin Psychiatry; 2012 Nov 15; 73(11):1403-11. PubMed ID: 23146246
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Fenfluramine challenge test in obsessive-compulsive disorder--first results.
    Pidrman V, Tůma I.
    Acta Medica (Hradec Kralove); 1997 Nov 15; 40(4):99-102. PubMed ID: 9481883
    [Abstract] [Full Text] [Related]

  • 20. Effect of zinc supplementation on antidepressant therapy in unipolar depression: a preliminary placebo-controlled study.
    Nowak G, Siwek M, Dudek D, Zieba A, Pilc A.
    Pol J Pharmacol; 2003 Nov 15; 55(6):1143-7. PubMed ID: 14730113
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.